Moving away (finally) from doublet therapy in lung cancer: immunotherapy and KEYNOTE-189.

Moving away (finally) from doublet therapy in lung cancer: immunotherapy and KEYNOTE-189. J Thorac Dis. 2018 Sep;10(9):5186-5189 Authors: Sheela S, Kim ES, Mileham KF PMID: 30416764 [PubMed]
Source: Journal of Thoracic Disease - Category: Respiratory Medicine Tags: J Thorac Dis Source Type: research